Physician profile
Michael Duval
NPI 1568469336
$11,178.77
in general payments reported to CMS, 2019-2025
14 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $1,447 · 2021: $618 · 2022: $3,110 · 2023: $2,737 · 2024: $2,185 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,648 · Food and Beverage: $2,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,648.18 |
| Food and Beverage | $2,483.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,919.53 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $2,706.11 | 2020-2022 | |
| Alon Medical Technology | $2,436.87 | 2019-2025 | |
| Stryker Corporation | $1,573.00 | 2020-2024 | Mako, Omega, Inspace |
| Ethicon US, LLC | $146.32 | 2020-2025 | Stratafix, Vistaseal |
| Smith+Nephew, INC. | $122.50 | 2024-2025 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, N/A |
| Vericel Corporation | $78.66 | 2022-2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $57.72 | 2023-2024 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $34.87 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $30.03 | 2025 | Euflexxa |
| Kci USA, INC. | $25.95 | 2020-2021 | |
| Boston Scientific Corporation | $16.33 | 2025 | General - Pain Management |
| Convatec INC. | $16.06 | 2024 | |
| Abiomed | $14.82 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Duval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.